| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2012 | US20120014981 Avirulent, immunogenic flavivirus chimeras |
| 01/19/2012 | US20120014977 NOVEL ALTERNATIVE SPLICING VARIANT OF OATP1B3 mRNA |
| 01/19/2012 | US20120014967 Il-1beta binding antibodies and fragments thereof |
| 01/19/2012 | US20120014964 Alpha synuclein toxicity |
| 01/19/2012 | US20120014961 Antibodies that inhibit tslp activity |
| 01/19/2012 | US20120014960 Composition Comprising Antibodies to LINGO or Fragments Thereof |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |
| 01/19/2012 | US20120014957 Dual variable domain immunoglobulins and uses thereof |
| 01/19/2012 | US20120014948 Genetic products differentially expressed in tumors and use thereof |
| 01/19/2012 | US20120014942 Method for the diagnosis and prognosis of malignant diseases |
| 01/19/2012 | US20120014941 Anti-bv8 antibodies and uses thereof |
| 01/19/2012 | US20120014935 Recombinant human cln2 protein and methods of its production and use |
| 01/19/2012 | US20120014928 Methods and compositions for targeted cleavage and recombination |
| 01/19/2012 | US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION |
| 01/19/2012 | US20120014872 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers |
| 01/19/2012 | DE112009002267T5 Pflanzen mit erhöhtem Ertrag (LT) Plants having increased yield (LT) |
| 01/19/2012 | DE112009002224T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
| 01/19/2012 | DE112009001994T5 Pflanzen mit erhöhtem Ertrag durch Erhöhen oder Erzeugen einer oder mehrerer Aktivitäten in einer Pflanze oder einem Teil davon Plants with increased yield by increasing or generating one or more activities in a plant or part thereof |
| 01/19/2012 | DE102010031404A1 Verfahren zur schnellen Bereitstellung von Inhaltsstoffen aus biologischen Proben Method for the rapid deployment of ingredients from biological samples |
| 01/19/2012 | DE102010031401A1 Verfahren zur Anreicherung von Bakterien, Viren sowie Zellen und zur nachfolgenden Nukleinsäureisolierung A method for enrichment of bacteria, viruses and cells and for subsequent nucleic acid isolation |
| 01/19/2012 | DE102009008252B4 Autokatalytischer Proteinlinker und seine Verwendung zur Herstellung von Fusionsproteinen Autocatalytic protein linker and its use for the production of fusion proteins |
| 01/19/2012 | CA2805875A1 Antibody libraries |
| 01/19/2012 | CA2805643A1 Targeted nanoparticles for cancer and other disorders |
| 01/19/2012 | CA2805620A1 Methods for producing proteins in plants |
| 01/19/2012 | CA2805479A1 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides |
| 01/19/2012 | CA2805408A1 Novel nitrate reductase fusion proteins and uses thereof |
| 01/19/2012 | CA2805318A1 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
| 01/19/2012 | CA2805306A1 Diagnostic method for colitis |
| 01/19/2012 | CA2805300A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | CA2805170A1 Gene therapy composition for use in diabetes treatment |
| 01/19/2012 | CA2804728A1 Nucleic acid construct for increasing abiotic stress tolerance in plants |
| 01/19/2012 | CA2804713A1 Metabolically engineered organisms for the production of added value bio-products |
| 01/19/2012 | CA2803944A1 Method for the isolation of proteins binding to any kind nucleic acid sequence of interest |
| 01/19/2012 | CA2803011A1 Retrovirus detection |
| 01/19/2012 | CA2802173A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/18/2012 | EP2407561A2 A method for the preparation of recombinant human fibrinogen |
| 01/18/2012 | EP2407559A2 Genomics-based quality diagnostics for fresh agricultural products |
| 01/18/2012 | EP2407557A2 Apparatus for integrated real-time nucleic acid analysis, and method for detecting a target nucleic acid using same |
| 01/18/2012 | EP2407556A1 Method for determining sensitivity to irinotecan and use thereof |
| 01/18/2012 | EP2407551A2 Composition for analyzing nucleic acid |
| 01/18/2012 | EP2407545A1 Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites |
| 01/18/2012 | EP2407544A1 Production method for 1,3-propanediol using recombinant microbial strain having glycerol oxidation metabolic pathway blocked |
| 01/18/2012 | EP2407543A1 Use of a nucleotide sequence that regulates flowering time, plants expressing same and production method thereof |
| 01/18/2012 | EP2407542A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/18/2012 | EP2407541A1 Global transcription machinery engineering |
| 01/18/2012 | EP2407540A1 Method for purifying a target nucleic acid |
| 01/18/2012 | EP2407539A1 MULTIMERIC siRNA AND PREPARATION METHOD THEREFOR |
| 01/18/2012 | EP2407538A1 Reporter vector for use in evaluation of CYP1A2 |
| 01/18/2012 | EP2407488A2 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 01/18/2012 | EP2407486A1 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 01/18/2012 | EP2407483A1 Methods of treating, diagnosing or detecting cancers |
| 01/18/2012 | EP2407482A1 Lactobacillus acidophilus nucelic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 01/18/2012 | EP2407481A1 Lactobacillus acidophilus nucelic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 01/18/2012 | EP2407177A1 Adenovirus vaccine vectors |
| 01/18/2012 | EP2407173A1 Method and compositions to induce apoptosis of tumoral cells expressing SHH |
| 01/18/2012 | EP2407171A2 Compositions and methods for the treatment of ophthalmic disease |
| 01/18/2012 | EP2406401A2 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
| 01/18/2012 | EP2406395A1 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene |
| 01/18/2012 | EP2406386A1 Method for improving the yield of a polypeptide |
| 01/18/2012 | EP2406380A1 Drought tolerant plants and methods involving genes encoding type c3hc4 ring finger zinc-finger family polypeptides |
| 01/18/2012 | EP2406379A1 Compositions and methods for the delivery of biologically active rnas |
| 01/18/2012 | EP2406378A1 Biofuel production in prokaryotes and eukaryotes |
| 01/18/2012 | EP2406377A2 A polynucleotide and polypeptide sequence and methods thereof |
| 01/18/2012 | EP2406376A1 LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES |
| 01/18/2012 | EP2406375A1 Cell-specifically effective molecules on the basis of sirna and application kits for the production thereof and use thereof |
| 01/18/2012 | EP2406374A1 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents |
| 01/18/2012 | EP2406372A1 Pregastric esterase and derivatives thereof |
| 01/18/2012 | EP2406290A2 Antigen presenting cell targeted cancer vaccines |
| 01/18/2012 | EP2406289A2 Antigen presenting cell targeted anti-viral vaccines |
| 01/18/2012 | EP2406288A2 Antigen presenting cell targeted vaccines |
| 01/18/2012 | EP2406286A2 Anti-cd40 antibodies and uses thereof |
| 01/18/2012 | EP2406285A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 01/18/2012 | EP2406283A1 Antibody molecules having binding specificity for human il-13 |
| 01/18/2012 | EP2406282A1 Interleukin-21 variants having antagonistic binding to the il-21 receptor |
| 01/18/2012 | EP2406280A1 Biological materials and uses thereof |
| 01/18/2012 | EP2406278A2 Axmi-001, axmi-002, axmi-030, axmi-035, and axmi-045: insecticidal proteins from bacillus thuringiensis and methods for their use |
| 01/18/2012 | EP2406277A1 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector |
| 01/18/2012 | EP2405959A1 Methods, apparatuses, and kits for introducing genetic material into living cells |
| 01/18/2012 | EP2405945A2 Non-integrating retroviral vector vaccines |
| 01/18/2012 | EP2405939A1 Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against antigens in replication deficient recombinant virus vaccines |
| 01/18/2012 | EP2405921A1 Compositions and methods for silencing apolipoprotein c-iii expression |
| 01/18/2012 | EP1991661B1 Strains of lactobacillus helveticus which do not ferment lactose |
| 01/18/2012 | EP1950294B1 Novel cell penetrating peptide |
| 01/18/2012 | EP1902136B1 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
| 01/18/2012 | EP1883701B1 Expression of viral proteins in plants |
| 01/18/2012 | EP1866414B1 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 01/18/2012 | EP1836298B1 COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1799829B1 Method for production of a compound in a eukaryotic cell |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1704234B1 Production of glucagon like peptide 2 and analogs |
| 01/18/2012 | EP1672066B1 Dna fragment, method for producing transformant for protein production and utilization thereof |
| 01/18/2012 | EP1668120B1 Method for detecting cancer cells and monitoring cancer therapy |
| 01/18/2012 | EP1659858B1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/18/2012 | EP1587924B2 Methods for site-directed mutagenesis and targeted randomization |
| 01/18/2012 | EP1546327B1 Selection and isolation of living cells using rna-binding probes |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1456366B1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 01/18/2012 | EP1446489B1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 01/18/2012 | EP1423508B1 Protein phosphatase stress-related polypeptides and methods of use in plants |